Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations

Authors

Keywords

Journal

Volume 32, Issue -, Pages 39-48

Publisher

Elsevier BV

Online

2011-10-25

DOI

10.1016/j.jmgm.2011.10.005

Explore over 38,000 international journals covering a vast array of academic fields.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started